ERBB2 and neoplasm: We therefore examined the expression of ER, PgR, HER2, Ki67, and tumor-infiltrating lymphocytes (TILs), as well as nuclear and histological grades, in tumor specimens from patients enrolled in these two studies using the currently available measurement methods.